J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug

J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug

Submitted by admin on September 28, 2023 - 12:08pm
Source: 
Reuters
News Tags: 
JNJ
non-small cell lung cancer
AstraZeneca
Rybrevant
lazertinib
Tagrisso
Headline: 
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
snippet: 

Johnson & Johnson (JNJ.N) said on Thursday its cancer drug combination helped patients with a type of non small-cell lung cancer live longer without the disease worsening compared with AstraZeneca's (AZN.L) blockbuster cancer drug Tagrisso.

Do Not Allow Advertisers to Use My Personal information